Adrenoleukodystrophy Clinical Trials
2 recruiting trials for Adrenoleukodystrophy. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Adrenoleukodystrophy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Children's Hospital of Philadelphia (1), Masonic Cancer Center, University of Minnesota (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Medical Record Abstraction (other, 1 trial), followed by Biospecimen Sample Collection.
Track Adrenoleukodystrophy trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The Myelin Disorders Biorepository Project
The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and...
Adrenoleukodystrophy National Registry Study
The aim of this registry to understand the natural history and disease progression in ALD and potentially develop bio-markers using the biospecimens collected using this registry.
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Adrenoleukodystrophy, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Adrenoleukodystrophy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Adrenoleukodystrophy, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.